Graham Capital Management, L.P. Arvinas, Inc. Transaction History
Graham Capital Management, L.P.
- $5.17 Billion
- Q2 2025
A detailed history of Graham Capital Management, L.P. transactions in Arvinas, Inc. stock. As of the latest transaction made, Graham Capital Management, L.P. holds 234,628 shares of ARVN stock, worth $2.38 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
234,628
Previous 301,304
22.13%
Holding current value
$2.38 Million
Previous $2.12 Million
18.39%
% of portfolio
0.03%
Previous 0.05%
Shares
8 transactions
Others Institutions Holding ARVN
# of Institutions
245Shares Held
68.6MCall Options Held
2.99MPut Options Held
534K-
Vanguard Group Inc Valley Forge, PA9.39MShares$95.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.26MShares$63.5 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.67MShares$37.3 Million0.0% of portfolio
-
Logos Global Management LP San Francisco, CA3.3MShares$33.5 Million3.14% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.15MShares$21.8 Million0.01% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $540M
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...